SCHEMBL6813729

SCHEMBL6813729

N#Cc1ccc(NC(=O)c2cc(-c3ccccc3)on2)c(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.55
STAT3 P40763 1/20 0.54
STAT1 P42224 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
NPC1 O15118 3/20 0.53
SCD O00767 3/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ALDH1A1 P00352 4/20 0.51
PPARG P37231 1/20 0.51
NCOA2 Q15596 1/20 0.51
NCOA1 Q15788 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
ACR P10323 1/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
XBP1 P17861 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833885 0.91 TDP1 (0.49) TDP1STAT3STAT1MEN1KMT2A
SCHEMBL6818740 0.87 RXFP1 (0.71) MEN1KMT2ANPC1RXFP1ALDH1A1
SCHEMBL6821776 0.87 NPC1 (0.51) TDP1MEN1KMT2ANPC1SCD
SCHEMBL6833848 0.87 KMT2A (0.56) TDP1MEN1KMT2ANPC1SCD
SCHEMBL6833933 0.87 NPC1 (0.54) TDP1MEN1KMT2ANPC1ALDH1A1
SCHEMBL6818931 0.87 KMT2A (0.60) TDP1STAT3STAT1MEN1KMT2A
SCHEMBL6833424 0.86 TDP1 (0.46) TDP1STAT3STAT1MEN1KMT2A
SCHEMBL6818791 0.86 HSD17B10 (0.48) TDP1STAT3STAT1MEN1KMT2A
SCHEMBL6834026 0.86 KMT2A (0.46) TDP1STAT3STAT1MEN1KMT2A
SCHEMBL6830647 0.86 KMT2A (0.49) TDP1MEN1KMT2ANPC1SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 TDP1 2738/4885STAT3 943/4885STAT1 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.